Plant Health Care Share Discussion Threads

[oapknob1] 05/11/2021 06:33

1.Organic technology protects soybeans and makes crops sustainableWith Saori, Plant Health Care has developed a sustainable product capable of increasing plant rust control.Brazilian agribusiness has a set of technological tools and solutions to increase the quality control of soybeans.However, Plant Health Care, with its arm in Brazil, has taken a leap of innovation by developing an organic technology that increases the control of soybean rust, from plant germination to grain harvesting, increasing its productivity.Being the first peptide PREtec (Plant Response Elicitor technology) approved in national territory by the Ministry of Agriculture, Livestock and Supply (Mapa), the technology was named by Plant Health Care Brazil as Saori ("sacred soil") and, for the time being, serves exclusively Brazilian sojicultores.The product will be commercialized in the 2021/2022 crop through an unprecedented partnership with Nutrien Ag Solutions to launch the new Saori soybean seed treatment in Brazil."Derived from proteins of natural occurrence in the environment, PREtec peptides represent a new class of technology that stimulates plant defenses through physiological action, promoting activation of gene expression," explains Sérgio de Almeida, technical and regulatory manager at PHC Brazil.He assures, from studies conducted by the company, that "there is an increase of 19% to 22% in the effectiveness of fungicide control over the disease".Brazil is the world's largest soybean producer, with more than 40 million hectares (99 million hectares) with planting planned for the 2021/22 harvest.Asian soybean rust, caused by the fungus Phakopsora pachyrhizi, is a devastating disease that can lead to crop productivity loss of up to 90%.Brazilian soybean producers spent US$ 2.85 billion on disease control in the 2019/20 crop.

[oapknob1] 05/11/2021 05:58

Our technology is featured in the Massachusetts Institute of Technology magazine!Being present in this publication of such importance to fostering innovation demonstrates that we are fulfilling our mission: developing biologically natural revolutionary solutions, aligned to the highest standards of handling and conservation of the environment.SAORI ™., acts in control of Asian soya rust from germination to harvest, expanding its productivity and ensuring return on investment made by the producer.It's the technology of @Plant Health Care Brasil in the service of active, healthy and sustainable agriculture #breakingupbarriersdroductivity.#agro #agronegócio #phc #harpin #h2copla #bioinsumos #sustentabilidade #produtividadehttps://mitsloanreview.com.br/post/tecnologia-organica-protege-soja-e-torna-lavouras-sustentaveis

[oapknob1] 31/10/2021 13:42

They are working hard to increase awareness and promote PHC products. IMHO the current share price is a bargain for long term investment. Another excellent analysis from the Agronomist and Professor Doutor Agro-Marcos Fava Neves on the international energy crisis during the ?? Campo in Focus with Dr. Agro ?? on yesterday's Megacana Tech Show! As he rightly put it, the consequences that our field has suffered from the lack of inputs to supply the supply chain demand immediate attitudes, such as the greater use of Bioinsumos, which increase the efficiency of plants in using the resources provided to them.Thus, we will ensure the expansion that our agriculture is presenting despite the adversity. Since 2018, Harpin protein has been helping Brazilian farmers break through productivity barriers.H2COPLA is a Bioinsumo that activates plant physiology, promoting greater radicular growth, providing greater absorption of water and nutrients that help the plant dribble water stress and contributes to constant productivity gains and profitability to farmer in all crops.At a time when low availability and high cost of fertilizer can impact productivity, we know that H2COPLA will make a difference, increasing plant efficiency in using existing fertilizer.https://www.youtube.com/watch?v=IoaG6r672zoIt's Plant Health Care Brazil #breakingupproductivitybarriers#megacana #agro #agronegócio #phc #harpin #h2copla #bioinsumos #sustentabilidade

[oapknob1] 31/10/2021 13:40

Plant Health Care Brasil congratulates Nutrien Soluções Agrícolas on launching experience centres and establishing a new concept in addressing rural producer s' needs.With José Roberto Mendonça de Barros and his vast experience in the agribusiness world, Andre Dias, Presidente Latin America of Nutrien, Carlos Brito, Julio Cesar Ferreira Elias and Julieta Fernandes. With our General Director, Rodrigo Egéa de Miranda, and Gustavo Yepez Gil.It's PHC Brazil #breakinguptheproductivitybarriers#agro #agronegócio #phc #harpin #saori #bioinsumos #soja #produtividade #sustentabilidade

[geraldus] 29/10/2021 17:12

PHC on the Proactive Forum event on 4th November.Free to register.

[kaos3] 21/10/2021 21:49

griffiths needs money for his weshop deal

[1pencil] 21/10/2021 21:34

Its losing around $5 million a year and increasing, current valuation a staggering 37m GBP.

If Griffiths is selling (according to one poster) that speaks volumes having been invested for years.

Climate change is a big unknown, yes, there could be some upside for PHC from this but equally it could upset existing stable crops just as much.

[oapknob1] 21/10/2021 21:17

If sales keep growing think 27p will be achieved easily. IMHO DYOR Launches since 2019 are now delivering accelerated on-ground sales, which will bring more consistent, balanced and profitable revenue growth for Plant Health Care.

[callumross] 21/10/2021 19:16

Unbelievable. Rewarded for failure. I remember 5 years ago when the shares were worth over £1 a share!

[1pencil] 20/10/2021 23:55

Glad to see its performance related..

Looking forward to greater clarity over this years dental plan.

[oapknob1] 20/10/2021 23:36

27p next performance based target for remaining 30% of CEO options then.

[oapknob1] 20/10/2021 23:29

Be interesting to see if the CFO and COO follow suit too. Might be another couple of RNS announcements to come.Performance-Based Requirement:(i) In respect of 70% of the options (rounded to the nearest whole number) no option may be exercised until the date on which the arithmetic mean closing price of the Company's shares over 30 consecutive trading dates after the date of grant has exceeded 15p per share; and(ii) In respect of the balance of the options, no options may be exercised until the date on which the arithmetic mean closing price of the Company's shares over 30 consecutive trading days after the date of grant has exceeded 27p per share.Service-Based Requirement: for all United States employees no option shall be exercised before the two-year anniversary of the date of grant.Those options that have not vested will expire after five years from the date of grant. All options are also fully convertible at the discretion of the Remuneration Committee of the Company.Of the options granted, the following awards have been made to the executive directors, being Chris Richards, Jeffrey Hovey and Jeffrey Tweedy.Chief Executive Officer Christopher Richards -3,250,000 Chief Financial Officer Jeffrey Hovey -1,181,818 Chief Operating Officer Jeffrey Tweedy -1,181,818

[oapknob1] 20/10/2021 23:02

18:03 RNS todayRNS Number : 7314PPlant Health Care PLC20 October 2021The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.Plant Health Care plc("Plant Health Care" or "the Company")Exercise of Options, Issue of Equity, Director / PDMR Shareholdingand Total Voting RightsPlant Health Care, a leading provider of novel patent-protected biological products to global agricultural markets, announce s that on 20 October 202 1 Christopher Richards, Chief Executive Officer, exercised optionsAs announced on 7 October 2020, the Company had awarded 3,250,000 Options to Christopher Richards with an exercise price of 1p per ordinary share in the Company (the ' Ordinary Shares ') under the Plan that vest upon the earlier of: (a) the date of a Change of Control; or (b) upon satisfaction of the Performance-Based Requirement. The Performance-Based Requirement i n respect of 70% of the O ptions (rounded to the nearest whole number) is that no O ption may be exercised until the date on which the arithmetic mean closing price of the Ordinary S hares over 30 consecutive trading dates after the date of grant has exceeded 15p per S hare . This criteria was achieved earlier this year and Dr Richards has now decided to exercise 2,275,000 Options.Of the 2,275,000 Ordinary Shares to be issued (the ' New Ordinary Shares ') following the exercise of the Options, Christopher Richards has sold 879,042 Ordinary Shares at an aggregate price of GBP100,146.06, being enough Ordinary Shares to cover the exercise price and associated tax liabilities in respect of the Ordinary Shares issued. Following these transactions, Dr Richards is interested in 4,370,973 Ordinary Shares representing 1.43% of the issued share capital of the Company.Application for admission of the New Ordinary Shares to trading on AIM ('Admission') has been made and dealings in the New Ordinary Shares are expected to commence at 8.00 a.m. on 26 October 2021. The New Ordinary Shares will rank pari-passu with the Company's existing issued Ordinary Shares.Total voting rightsFollowing Admission, the Company will have 304,662,482 Ordinary Shares in issue with no shares held in treasury. This is the total number of voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

[oapknob1] 17/10/2021 23:01

If the uptake for Saori is good during the initial limited launch then it's safe to assume it will be good when full launch occurs 2022-23 growing season. Good news in January or a sniff before then and you maybe paying much more than the current share price

[kaos3] 17/10/2021 05:26

phc is in "slow" business

- it takes time for the research
- to patent
- to get the approval in specific region
- to get the selling traction and the adoption
sp cant be fast

so I ll do the waiting before buying

[oapknob1] 16/10/2021 22:23

Next trading update maybe around 25th January 2022 if they follow on from last year.

[oapknob1] 13/10/2021 16:40

Up 8.8% yeah right on nothing trades.Wonder how it will rise an update re sales.

[oapknob1] 01/10/2021 21:16

Maybe not misread,

[oapknob1] 01/10/2021 21:15

PHC only mentioned 40 million so projection is more than double,About 99 million acres are expected to be devoted to soybeans,

[oapknob1] 01/10/2021 20:54

Farmers in Brazil began planting in September for what is expected to be a recording-breaking 2021-2022 harvest. The first projection from CONAB (National Supply Company in Brazil) projects farmers will produce 289.6 million tons of soybeans, corn, cotton, rice, and beans – accounting for nearly 95% of the total grain produced in Brazil.About 99 million acres are expected to be devoted to soybeans, and about 51 million acres to corn, both records. The projections are based on high international prices and profits in 2021, depreciation of the Brazilian real relative to the U.S. dollar, an expected increase in exports, and the profitability forecast for 2022.Brazil is likely to remain the world leader in soybean production in the next crop year, followed by the United States and Argentina. Brazilian soybean acreage is expected to grow 3.6%, to 98.62 million acres, according to CONAB. Most of the acreage increase is expected to be the conversion of pasture to soybean acre. The 2021-2022 soybean crop in Brazil is projected to be 5,190 million bushels, the highest in history, an increase of 3.9% over the previous harvest.Historically high prices and profits in 2021, coupled with optimistic expectations for the next harvest and the depreciation of the real relative to the dollar, are motivating farmers to increase the acreage they plant. It is important to highlight that the price of soybeans in the Brazilian market is formed by the three following factors: international prices, port premium, and the dollar. All three factors are expected to remain high in 2022 because of the low world stock-to-consumption ratio, and the increase in domestic consumption.Brazilian soybean exports and the crush are expected to increase in 2022, driving the increase in acreage planted. The demand for more biodiesel fuel and the high consumption of animal feed also are expected to fuel domestic demand in Brazil next year.The soybean crush is projected at 1,891 million bushels, a 10.7% increase over this year. Chinese demand and a weak real with a strengthening U.S. dollar will drive an increase in soybean exports. Soybean sales are projected to reach 3,218 million bushels next year, 5 percent higher than this year, according to CONAB report.

[oapknob1] 01/10/2021 20:50

Planting has started in Brazil.Bom Futuro said the start of rainfall in Mato Grosso, Brazil's top grain producing state, had led to optimistic projections for the planting of both soybean and cotton, which will be sowed in late December."Weather forecasts show us that rains should continue in the state, so we are looking at yields between 70 to 72 bags per hectare (for soybean)", Bom Futuro's production director Inacio Modesto Filho said in a statement.The company expects to produce 1.22 million tonnes of soybeans in the 2021/2022 season, versus 1.17 million tonnes in 2020/2021.

[oapknob1] 01/10/2021 11:32

Sales numbers for Saori. Once they start coming in things should change